2-181677112-A-ATT
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_002500.5(NEUROD1):c.*676_*677dupAA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.066 ( 792 hom., cov: 0)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
NEUROD1
NM_002500.5 3_prime_UTR
NM_002500.5 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.959
Genes affected
NEUROD1 (HGNC:7762): (neuronal differentiation 1) This gene encodes a member of the NeuroD family of basic helix-loop-helix (bHLH) transcription factors. The protein forms heterodimers with other bHLH proteins and activates transcription of genes that contain a specific DNA sequence known as the E-box. It regulates expression of the insulin gene, and mutations in this gene result in type II diabetes mellitus. [provided by RefSeq, Jul 2008]
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0821 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROD1 | NM_002500.5 | c.*676_*677dupAA | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000295108.4 | NP_002491.3 | ||
NEUROD1 | NR_146175.2 | n.88+3316_88+3317dupAA | intron_variant | Intron 1 of 1 | ||||
NEUROD1 | NR_146176.2 | n.88+3316_88+3317dupAA | intron_variant | Intron 1 of 1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0665 AC: 3273AN: 49224Hom.: 792 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
3273
AN:
49224
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 80Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 50
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
80
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
50
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
78
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
AC:
0
AN:
2
GnomAD4 genome AF: 0.0665 AC: 3273AN: 49246Hom.: 792 Cov.: 0 AF XY: 0.0610 AC XY: 1311AN XY: 21492 show subpopulations
GnomAD4 genome
AF:
AC:
3273
AN:
49246
Hom.:
Cov.:
0
AF XY:
AC XY:
1311
AN XY:
21492
show subpopulations
African (AFR)
AF:
AC:
412
AN:
13758
American (AMR)
AF:
AC:
162
AN:
2870
Ashkenazi Jewish (ASJ)
AF:
AC:
111
AN:
1520
East Asian (EAS)
AF:
AC:
154
AN:
1720
South Asian (SAS)
AF:
AC:
66
AN:
1232
European-Finnish (FIN)
AF:
AC:
20
AN:
476
Middle Eastern (MID)
AF:
AC:
0
AN:
34
European-Non Finnish (NFE)
AF:
AC:
2267
AN:
26670
Other (OTH)
AF:
AC:
36
AN:
598
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.569
Heterozygous variant carriers
0
46
92
138
184
230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Maturity onset diabetes mellitus in young Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.